January 30, 2026
1 min read

Approved Immunotherapy, Keytruda, Shrinks, Eliminates Rare, Aggressive Melanoma, Clinical Trial Finds MedNews

FRIDAY, Jan. 30, 2026 An already-approved immunotherapy drug can dramatically shrink or even eliminate tumors associated with a rare and aggressive form of mela

Leave a Reply

Your email address will not be published.

Previous Story

When wars drive hunger, nutrition delivery becomes the industry bottleneck

Next Story

Afternoon Naps Are Good For The Brain — And Researchers Now Know Why MedNews

Previous Story

When wars drive hunger, nutrition delivery becomes the industry bottleneck

Next Story

Afternoon Naps Are Good For The Brain — And Researchers Now Know Why MedNews

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop